DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
P•• F•••••••• M••••• S•• L••
Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $98.0M
sum of BDC pieces, a lower bound
Fair value
$96.2M
100c on cost, debt pieces
Unfunded
$21.0M
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
Feb 13, 2032
no dated debt inside 24 months
On the tape since
Sep 30, 2024
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $98.0M | 100c | S+475 bp | Feb 13, 2032 | 2 |
| first lien revolver first lien | at least $0 | n/a | S+475 bp | Feb 13, 2032 | 2 |
Equity pieces beside the debt: other (n/a fair value, 2 BDCs)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | term loan first lien F•••• L••• T••• L••• | $24.3M | $23.9M 100c | S+475 bp |
| O•••••• S•••••••• L•••••• C••• | unstated lien unstated | n/a | n/a | |
| O•••••• S•••••••• L•••••• C••• | revolver first lien F•••• L••• R••••••• | $0 | $-78,000 124c | S+475 bp |
| O•••••• S•••••••• C••••• F••• | unstated lien unstated | n/a | n/a | |
| O•••••• S•••••••• C••••• F••• | term loan first lien F•••• L••• T••• L••• | $73.7M | $72.6M 100c | S+475 bp |
| O•••••• S•••••••• C••••• F••• | revolver first lien F•••• L••• R••••••• | $0 | $-237,000 125c | S+475 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $98.0M | $96.2M | 100c | 0 |
| Mar 31, 2026 | 2 | $100M | $98.8M | 100c | 0 |
| Dec 31, 2025 | 2 | $102M | $100M | 100c | 0 |
| Sep 30, 2025 | 2 | $98.8M | $97.0M | 100c | 0 |
| Jun 30, 2025 | 2 | $99.0M | $97.2M | 100c | 0 |
| Mar 31, 2025 | 2 | $99.0M | $97.2M | 100c | 0 |
| Sep 30, 2024 | 2 | $0 | $0 | n/a | 0 |
What changed
- New borrower on a BDC scheduleSep 30, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- PAI FINANCINGderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it